Xoma reported $4.79M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.3B 174M
Agenus AGEN:US USD 18.1M 809K
Agios Pharmaceuticals AGIO:US USD 29.12M 859K
Ardelyx ARDX:US USD 18.67M 195K
Biomarin Pharmaceutical BMRN:US USD 216.82M 19.98M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Celldex Therapeutics CLDX:US USD 6.53M 623K
Chimerix CMRX:US USD 5.31M 527K
Curis CRIS:US USD 9.11M 4.02M
Eli Lilly And LLY:US USD 1.61B 10.9M
Emergent Biosolutions EBS:US USD 80.2M 900K
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
Life Technologies LIFE:US USD 3.62M 176K
Macrogenics MGNX:US USD 15.35M 1.69M
Novartis NVS:US USD 3.4B 185M
Novartis NOVN:VX USD 3.4B 185M
Pfizer PFE:US USD 3.54B 345M
Prothena PRTA:US USD 11.99M 963K
Regeneron Pharmaceuticals REGN:US USD 529.1M 52.8M
Teva Pharmaceutical Industries TEVA:US USD 777M 72M
Xoma XOMA:US USD 4.79M 916K
YTE INCY:US USD 266.46M 13.18M